Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:283-289

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, Q.
Right arrow Articles by LaPointe, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, Q.
Right arrow Articles by LaPointe, M. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DACTINOMYCIN

(Hypertension. 1999;33:283-289.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Interleukin-1ß Regulation of the Human Brain Natriuretic Peptide Promoter Involves Ras-, Rac-, and p38 Kinase–Dependent Pathways in Cardiac Myocytes

Quan He; Margot C. LaPointe

From the Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Mich.

Correspondence to Dr Margot C. LaPointe, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202-2689. E-mail mclapointe{at}aol.com

Abstract—Because both the brain natriuretic peptide (BNP) gene and the cytokine interleukin-1ß (IL-1ß) are induced in the infarcted myocardium, localized production of IL-1ß may regulate the BNP gene. We tested whether (1) IL-1ß regulates the human BNP promoter, (2) cis elements in the proximal promoter respond to IL-1ß, and (3) mitogen-activated protein kinase (MAPK) signaling pathways [p42/44, c-jun (JNK) and p38 kinase] are involved. We transferred the hBNP promoter coupled to a luciferase reporter gene or constructs with mutations in the proximal promoter GATA and M-CAT elements into neonatal rat ventricular myocytes and treated the cells with IL-1ß for 24 hours. IL-1ß–stimulated hBNP luciferase activity was eliminated by pretreatment with the transcription inhibitor actinomycin D. Both the p38 kinase inhibitor SB205380 (SB) and cotransfection of a dominant-negative mutant of p38 kinase reduced IL-1ß stimulation of the hBNP promoter. Dominant-negative mutants of Ras and Rac inhibited IL-1ß–stimulated hBNP luciferase activity by 64% and 90%, respectively. Constitutively active forms of Rac and MKK6, the immediate upstream activator of p38, were stimulatory; however, only the effect of MKK6 was inhibited by SB. Neither the p42/44 nor the JNK pathway was involved in the action of IL-1ß. Both IL-1ß and MKK6 activation of the hBNP promoter were partially reduced when the promoter contained a mutated M-CAT element. In summary, (1) IL-1ß is a transcriptional activator of the hBNP promoter; (2) IL-1ß acts through a Ras-dependent pathway not coupled to activation of p42/44 MAPK or JNK; (3) IL-1ß acts through a Rac-dependent pathway, but the downstream effector is not known; and (4) IL-1ß activation of p38 kinase is partially involved in regulation of the hBNP promoter, targeting the proximal M-CAT element.


Key Words: cell signaling • peptides, natriuretic • cytokines • M-CAT element




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. R. Chaudhary, S. N. Batchu, D. Das, M. R. Suresh, J. R. Falck, J. P. Graves, D. C. Zeldin, and J. M. Seubert
Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function
Cardiovasc Res, July 15, 2009; 83(2): 362 - 370.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. P. Rivers, J. McCord, R. Otero, G. Jacobsen, and M. Loomba
Clinical Utility of B-Type Natriuretic Peptide in Early Severe Sepsis and Septic Shock
J Intensive Care Med, November 1, 2007; 22(6): 363 - 373.
[Abstract] [PDF]


Home page
HypertensionHome page
A. M. Richards
Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use
Hypertension, July 1, 2007; 50(1): 25 - 30.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Clerico, F. A. Recchia, C. Passino, and M. Emdin
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H17 - H29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. C. LaPointe, X.-P. Yang, O. A. Carretero, and Q. He
Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1439 - H1445.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F.-L. Tan, C. S. Moravec, J. Li, C. Apperson-Hansen, P. M. McCarthy, J. B. Young, and M. Bond
The gene expression fingerprint of human heart failure
PNAS, August 20, 2002; 99(17): 11387 - 11392.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Ogawa, Y. Saito, K. Kuwahara, M. Harada, Y. Miyamoto, I. Hamanaka, N. Kajiyama, N. Takahashi, T. Izumi, R. Kawakami, et al.
Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression
Cardiovasc Res, February 1, 2002; 53(2): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. M. Behr, S. S. Nerurkar, A. H. Nelson, R. W. Coatney, T. N. Woods, A. Sulpizio, S. Chandra, D. P. Brooks, S. Kumar, J. C. Lee, et al.
Hypertensive End-Organ Damage and Premature Mortality Are p38 Mitogen-Activated Protein Kinase-Dependent in a Rat Model of Cardiac Hypertrophy and Dysfunction
Circulation, September 11, 2001; 104(11): 1292 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. C Kone
Molecular biology of natriuretic peptides and nitric oxide synthases
Cardiovasc Res, August 15, 2001; 51(3): 429 - 441.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. D. O'Connell, D. G. Rokosh, and P. C. Simpson
Cloning and Characterization of the Mouse alpha 1C/A-Adrenergic Receptor Gene and Analysis of an alpha 1C Promoter in Cardiac Myocytes: Role of an MCAT Element That Binds Transcriptional Enhancer Factor-1 (TEF-1)
Mol. Pharmacol., April 16, 2001; 59(5): 1225 - 1234.
[Abstract] [Full Text]


Home page
HypertensionHome page
Q. He and M. C. LaPointe
Src and Rac Mediate Endothelin-1 and Lysophosphatidic Acid Stimulation of the Human Brain Natriuretic Peptide Promoter
Hypertension, February 1, 2001; 37(2): 478 - 484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. He, D. Wang, X.-P. Yang, O. A. Carretero, and M. C. LaPointe
Inducible regulation of human brain natriuretic peptide promoter in transgenic mice
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H368 - H376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. He, G. Wu, and M. C. Lapointe
Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1115 - E1123.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Palsson, M. Popoff, M. Thelestam, and L. A. J. O'Neill
Divergent Roles for Ras and Rap in the Activation of p38 Mitogen-activated Protein Kinase by Interleukin-1
J. Biol. Chem., March 10, 2000; 275(11): 7818 - 7825.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Li, Y. Hu, G. Sturm, G. Wick, and Q. Xu
Ras/Rac-Dependent Activation of p38 Mitogen-Activated Protein Kinases in Smooth Muscle Cells Stimulated by Cyclic Strain Stress
Arterioscler Thromb Vasc Biol, March 1, 2000; 20 (3): e1 - e9.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. He and M. C. LaPointe
Interleukin-1{beta} Regulates the Human Brain Natriuretic Peptide Promoter via Ca2+-Dependent Protein Kinase Pathways
Hypertension, January 1, 2000; 35(1): 292 - 296.
[Abstract] [Full Text] [PDF]